Background/Aims: Microarray screening had found BRAF-activated non-coding RNA (BANCR) potential role of long non-coding RNA (lncRNA) BANCR in the pathogenesis and progression of type 1 EC. Methods:
Introduction
Endometrial cancer (EC) is a prevalent female reproductive system tumor, and the third leading cause of gynecological cancer death. In western countries, it has the highest incidence of cancers affecting women [1] . The incidence of EC has signi icantly increased recently because of the expansion of high-risk groups, such as women with high leptin or adiponectin levels [2, 3] . In 1983, EC was divided into two types by its micro-morphological, clinical and epidemiological characteristics by Bokhman [4] . Although the incidence of type 1 EC is signi icantly higher than that of type 2, its pathogenesis remains unclear. The identi ication of new prognostic indicators and novel treatments is highly desired.
Potential medical applications of microRNAs (miRNAs) [5] , long non-coding RNAs (lncRNAs) have been received extensive attention. LncRNAs are longer than 200 nucleotides that do not have protein-coding function or encode insuf icient lengths of open reading frames, but participate in biologically important activities including X-chromosome silence [6] , chromatin modi ication [ ], transcriptional activation or interference [8] . The transcription of lncRNA can in luence transcription of a nearby gene by inhibiting the binding of transcription factors or changing the chromosomal conformation [9] . LncRNAs can also interact with miRNA as a competitive endogenous RNA to regulate the expression of target genes [10] . Emerging evidence indicates that lncRNAs play a critical role in the development and progression of various cancers. For example, Leucci et al. showed that lncRNA SAMMSON modulated mitochondrial metabolism in trans by targeting p32 to the mitochondria in melanoma [11] . H19 was highly expressed in bladder carcinoma, and overexpression of H19 promoted metastasis by upregulating E-cadherin via combination with EZH2 [12] . Over expression of MEG3 suppressed the proliferation of hepatoma cells and induced apoptosis [13] . MALAT1 promoted the proliferation and metastasis of gall bladder cancer cells via the extracellular signal-regulated kinase (ERK) / mitogen-activated protein kinase (MAPK) signaling pathway [14] . HOTAIR was highly expressed in epithelial ovarian cancer and promoted migration by regulating matrix metalloproteinases (MMPs) and the expression of genes involved in epithelial-mesenchymal transition [15] . Studies show that lncRNAs have the potential to become new diagnostic tools, and markers of prognosis, metastasis, and treatment response in cancers. However, little is known about the biological role of lncRNAs in EC.
We previously found that BRAF
V600E
-Activated Non-Protein-Coding RNA (BANCR) is signi icantly upregulated in type 1 EC by Arraystar Human LncRNA V3.0 microarray screening (Data not shown). BANCR is a 693 bp RNA on chromosome 9, and it was irst reported by Nicola [16] and Ross [1 ] by RNA-se screening for transcripts affected by the expression of the oncogene BRAF
. BANCR promoted melanoma cell migration and played important role in the development and progression of gastric cancer [18] , colorectal cancer [19] , and lung cancer [20] . Little is known about the role of BANCR in EC. But by coding and non-coding network (CNC) bioinformatics analysis [21] , we found a potential co-expression relationship of BANCR with MMP2 and MMP1. MMPs are the main enzymes participating in extracellular matrix degradation and remodeling. Both MMP1 [22] and MMP2 [23] were over-expressed in EC and are crucial for metastasis and invasion of surrounding tissue. BRAF mutation could up-regulate MMP1 via activating ERK pathway in invasive melanoma cells [24] . The ERK pathway is a key branch of MAPK and has been shown to take part in cell proliferation, differentiation, apoptosis, migration and invasion [25] . Blocking ERK/ MAPK signaling has been shown to suppress cancers progression via down-regulating MMP expression [26, 2 ] . In this study, we found that BANCR was over-expressed in type 1 EC, and analyzed the correlation with MMP2 and MMP1 expression. We studied the effect of BANCR on the proliferation, migration, and invasion of type 1 EC cells by regulating ERK/MAPK signaling pathway that regulated MMP1 and MMP2 expression in vitro.
Materials and Methods
Tissue sample collection After obtaining informed consent, malignant and benign endometrial tissue specimens were collected from 30 surgical patients with type 1 EC and 20 surgical patients with myoma of uterus. All diagnoses were pathologically con irmed. Patients who were free of other surgical, endocrine, immune, metabolic, and malignant diseases and had not received hormone treatment 3 months before this surgery were eligible. Fresh, sterile specimens were frozen in li uid nitrogen, and stored at -80 C. We recorded clinicopathological
Isolation of total RNA, reverse transcription, and quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Total RNA was isolated from tissues and cells using TRIzol reagent (9108, Invitrogen, Carlsbad, CA, USA). All steps were carried out under RNase-free condition. RNA concentration and optical density (OD) value were read by a UV spectrophotometer (Bio-Rad, California, USA). The reverse transcription reactions were performed by using a PrimeScript RT reagent kit (RR04 A, TaKaRa Bio Inc., apan). RT-PCRs were performed with a SYBR PremixEx Ta kit (RR420A, TaKaRa) and a LightCycler 480 (Roche Applied Science) following the manufacturers' protocols. Relative lncRNA and mRNA expression levels (means ± SD) were calculated using the 2
Ct method with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the endogenous control. Each sample was assayed in triplicate. The RT-PCR primers were designed by PrimerPremier5.0 software (Premier, Canada), and their se uences were shown in Table 1 .
Small interfering RNA (siRNA) transfection
LncRNA BANCR siRNA (si-BANCR) and a negative control (siRNA-NC) were purchased from GenePharma (Shanghai, China). The se uences of these siRNAs are shown in Table 2 . si-BANCR and siRNA-NC were transfected into HEC-1A and Ishikawa cells cultured in six-well plates by using Lipofectamine 2000 (Invitrogen), following the manufacturer's instructions. There are two types of controls in our study. First control is cell transfected with siRNA negative control (siRNA-NC) as showed in Table 2 . And the other control is cell without any siRNA-transfection, called mock control (Control). The knock-down effect of si-BANCR was assayed by RT-PCR after transfected for 48h as the manufacturer's instructions .
Cell proliferation assay
Cell proliferation rate was determined by using a Cell Counting Kit-8 (CCK-8; CK04, Dojindo Molecular Table 1 .Primer se uences used in RT-PCR Table 2 . siRNA se uences Technologies, Osaka, apan). Brie ly, HEC-1A or Ishikawa cells were seeded into 96-well plates and transfected with siRNA. After transfection for another 24, 48, 2, or 96 h, 10 l CCK-8 reagent was added to each well. Cell was incubated for another 3 h before measuring the absorbance at 450 nm with an enzyme-linked immunosorbent assay plate reader (Bio-Rad). The cell proliferation rate was calculated as the ratio of the OD values of the experimental and control groups. All assays were performed in triplicate.
six-well plates and cultured until reaching 90% con luence. A wound was created with a pipette tip, the cells were washed twice, and cultured in medium without FBS. The wound was observed and photographed at 0 h and 24 h using an inverted microscope (Nikon, apan). Cell migration ability was described as the number of cells that migrated into the wound. All assays were performed in triplicate.
Transwell migration assay and transwell invasion assay
Matrigel (BD Biosciences, New York, USA) was diluted with cold serum-free medium and incubated for 4 h until it solidi ied (for transwell invasion assay). After being starved for 24 h, 200 l siRNA transfected HEC-1A or Ishikawa cells (5×10 4 ) cultured in serum-free medium were seeded into the upper chambers of Transwell plates (8 m pores; Corning, New York, USA), and 600 l 20% FBS medium was added to the lower chamber as a chemoattractant. After the chambers were incubated at 3 C for 18 h (for migration assay) and 26 h (for invasion assay), cells could be seen in lower the chamber. Cells remaining on the top of the transwell chamber were scraped off with a cotton swab. Migration cells and invasive cells were ixed with 4% paraformaldehyde for 30 min, stained with 0.1% crystal violet for 30 min, and observed, photographed and counted using a light microscope. All assays were performed in triplicate.
Cell cycle assay siRNA transfected HEC-1A and Ishikawa cells ( 1×10 6 ) were ixed with cold 0% absolute ethyl alcohol overnight at 4 C. Cells was added 100 l RNase A reagent (Keygen Biotech, Nanjing, China), incubated at 3 C for 30 min, and stained in 400 l propidium iodide reagent (Keygen Biotech) for another 30 min. DNA content was assayed at 488 nm by a FACSCalibur low cytometer (Becton Dickinson) and analyzed by ModFit LT software (Verity Software House). All assays were performed in triplicate.
Western blot assay HEC-1A and Ishikawa cells were harvested, washed twice and lysed in RIPA buffer (Keygen Biotech), containing protease inhibitors and phosphatase inhibitors after transfection for 48-2 h. Protein concentration was determined using a bicinchoninic acid assay (BCA) kit (Thermo Scienti ic, MA, USA). Total protein was separated by 10% polyacrylamide gel electrophoresis and transferred onto 0.45 m polyvinylidene luoride membranes (Millipore, MA, USA). After blocking for 1 h, the membranes were incubated with speci ic primary antibodies overnight at 4 C followed by secondary antibodies for 2 h at room temperature. The intensity of the protein bands was measured with C300 imaging system (Azure Biosystem, USA) by enhanced chemiluminescence (ECL; Thermo Scienti ic) and relative concentration was calculated using uantity One software (Bio-Rad). 
Statistical analysis
All data were expressed as means ± standard deviation (SD). SPSS 1 .0 software (SSPS Inc., Chicago, USA) was used for the statistical tests. Student's t-test was used to determine the signi icance of two group differences. One-way analysis of variance analysis was used for multiple comparison. Chi-s uare tests were used to compare lncRNA BANCR expression and clinicopathological features. The Pearson correlation coef icient (r) was used for correlation analysis. P 0.05 (two-tailed) was considered to be signi icant.
Results

Expression of lncRNA BANCR in type 1 EC tissues
RT-PCR (Fig. 1A) revealed that the expression of lncRNA BANCR was signi icantly higher in type 1 EC tissues (9.002±1.303) than that in normal endometrium tissues (2.2 9±0.60 2) (P 0.01). According our previous differential expression pro ile of LncRNAs and mRNAs of EC (Data not shown) , CNC bioinformatics analysis that was done by Kangchen, Shanghai, China (Fig. 1B) suggested the possibility of co-expression of BANCR with MMP2 and MMP1. RT-PCR showed that expression of MMP2 and MMP1 were higher in type 1 EC tissues than normal endometrium tissues (P 0.05; Fig. 1C ). There was highly signi icant positive correlation between MMP2 mRNA and BANCR expression in type 1 EC tissues (r=0. 85, P 0.001; Fig. 1D ). There was also positive correlation of MMP1 mRNA and BANCR expression (r=0.488, P=0.0062; Fig. 1E ).
Relationship of lncRNA BANCR expression and patients clinicopathological variables
According to the literature method [28] , 30 type 1 EC tissues were divided into highand low-expression groups of 15 each using of the median BANCR expression level (Y=9.115) (Fig. 1F) . The level of BANCR expression was not correlated with age or menstruation status (both P>0.05), but it was signi icantly correlated with FIGO stage (P=0.010), pathological grade (P=0.023), myometrial invasion (P=0.049) and lymph node metastasis (P=0.025) ( Table 3) .
Interference effect of BANCR siRNA in type 1 EC cells
The expression of BANCR in Ishikawa and HEC-1A cells was assayed by RT-PCR after transfection of siRNA for 24h-48h. Compared with siRNA-NC transfected cells and control cells, BANCR expression in Ishikawa and HEC-1A cells transfected with si-BANCR-1 and si-BANCR-2 was decreased (P 0.01). The interference effect of si-BANCR was 0% to 90% ( Fig.  2A-B) .
In luence of BANCR on the proliferation of EC cell lines in vitro
The CCK-8 assay was used to determine whether lncRNA BANCR had an effect on the proliferation of Ishikawa and HEC-1A cells in vitro. The proliferation of both Ishikawa and HEC-1A cells decreased signi icantly after transfection with si-BANCR-1 and si-BANCR-2 compared with siRNA-NC-transfected cells and control cells (P 0.05; Fig. 3A-B) .
In luence of BANCR on the cell cycle of EC cell lines in vitro
To investigate whether BANCR in luence the cell cycle distribution of Ishikawa and HEC-1A cells in vitro, low cytometry was used to detect the percentage of cells in G0/G1, S, and G2/M. The percentage changes of cells in every phase were shown in Table 4 . The percentage of G0/G1 cells increased and the percentage of S decreased, signi icantly after transfection with si-BANCR-1 and si-BANCR-2, compared with siRNA-NC cells and control cells (P 0.05; Fig. 3C-F) .
Cyclin D1 is a kind of cell cycle protein, and its content changes periodically as cell cycle. Over-expression of cyclin D1 can form a complex with CDK4/6 to promote cell cycle 
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progression from G1 to S phase, which can promote the proliferation of cells [29, 30] . Bcl-2 is a kind of anti-apoptosis protein that inhibit cell cycle transforming of G1/S, which promote cell survival and inhibit cell apoptosis [31] . To better understand the in luence of BANCR on the cell cycle, the expression of Cyclin D1 and Bcl-2 protein were assayed by western blot (Fig. 4A-B) . The expression of Cyclin D1 and Bcl-2 protein were signi icantly reduced after transfection with si-BANCR, compared with siRNA-NC-transfected cells and control cells (P 0.05; Fig. 4C-D) .
The effects of BANCR on Ishikawa and HEC-1A cell migration and invasion
The effects of BANCR on the migration and invasion of Ishikawa and HEC-1A cells, were tested by wound healing, transwell migration and invasion assays. In the wound healing assay, the migration of both Ishikawa and HEC-1A cells was signi icantly decreased after si-BANCR-1 and si-BANCR-2 transfection compared with siRNA-NC and control (P 0.01; Fig. 5A-B) . In the transwell migration assay, the number of both Ishikawa and HEC-1A cells that migrated into the lower chamber was signi icantly reduced by si-BANCR-transfection (P 0.01; Fig. 5C-D) . In the transwell invasion assay, the number of Ishikawa and HEC-1A cells that invaded into the lower chamber was also signi icantly decreased by si-BANCRtransfection (P 0.01; Fig. 5E-F) . 
In luence of BANCR on the ER AP signaling pathway and expression of P and P1
Western blot assays were used to detect the in luence of BANCR on the ERK/MAPK signaling pathway (Fig. 6A-B) . Compared with control cells and siRNA-NC-transfected cells, the expression of phosphorylated-MEK (P-MEK) and phosphorylated-ERK1/2 (P-ERK1/2) protein of Ishikawa and HEC-1A si-BANCR-transfected cells were signi icantly decreased (P 0.05); total-MEK (T-MEK) and total-ERK1/2 (T-ERK1/2) protein expression was not changed (Fig. 6C-D) .
RT-PCR and western blots were used to assay the expression of MMP2 and MMP1 mRNA and protein after transfected with si-BANCR and treated with U0126, an inhibitor of MEK/ERK/MAPK, inhibiting of ERK/MAPK signaling specially. Compared with control cells and siRNA-NC-transfected cells, the expression of MMP2 and MMP1 mRNA (Fig. A-B) and protein ( Fig. C-F) in Ishikawa and HEC-1A cells transfected with si-BANCR or treated with U0126 were signi icantly reduced (P 0.05). Between cells transfected with si-BANCR and treated with U0126, there were no signi icant differences in the expression level of MMP2 (P>0.05). However, between cells transfected with si-BANCR and added U0126, there was signi icant difference in MMP1 expression (P 0.05, Table 5 ). The results showed that lncRNA BANCR promoted EC-cell proliferation, migration and invasion by at least in part directly activating ERK/MAPK signaling pathway then to regulate MMP2/MMP1 expression.
Discussion
The worldwide incidence of EC has been increasing, and the pathogenesis of EC has not been well understood yet [1] . The pathological grade of type 1 EC tends to be high or moderate rather than low, but some patients still have a poor prognosis because of distant metastasis or lymph node invasion. Therefore, studying the pathogenesis of type 1 EC may help in prevention, diagnosis, treatment and the improvement of prognosis.
High-throughput microarray has been used to screen and identify speci ic lncRNAs as new markers of some cancers. Selective silencing lncRNA therapy mediated by RNA interference might become a treatment option for some cancers. According to our previous Arraystar Human LncRNA V3.0 microarray (Data not shown), we found that lncRNA BANCR is one of signi icantly upregulated lncRNAs in type 1 EC. In our study, we con irmed that the expression level of BANCR in type 1 EC tissues was higher than that in normal endometrium tissues by RT-PCR. And BANCR expression level was signi icantly correlated with FIGO stage, pathological grade, myometrial invasion, and lymph node metastasis. The results indicated that high expression of BANCR might prompt the progression of type 1 EC.
In vitro, knockdown of lncRNA BANCR suppressed the proliferation of Ishikawa and HEC-1A cells, arrested the cell cycle at G0/G1 and signi icantly decreased the percentage of cells in S phase. The levels of Cyclin D1 and Bcl-2 proteins were signi icantly reduced after BANCR-knockdown, showing that BANCR may promote proliferation and inhibit apoptosis of EC cells through up-regulating Cyclin D1 and Bcl-2. The migration and invasion of Ishikawa and HEC-1A cells were signi icantly decreased after si-BANCR transfection in wound healing, transwell migration and invasion assays. These results indicate that BANCR had a signi icant in luence on proliferation, migration, and invasion of type 1 EC cells. In 2014, Li et al. [32] reported that BANCR promoted melanoma proliferation by activating the ERK1/2 and NK MAPK signaling pathway. BANCR was highly expressed in colorectal cancer, and participated in EMT via the MEK/ERK pathway [19] . BANCR promoted proliferation and migration of lung cancer cells through inactivating P38 and NK MAPK [20] . The MAPK signaling pathway, especially ERK/MAPK was highly activated, correlated with the EC FIGO stage, and in luenced proliferation and apoptosis of EC cells [33] . Study suggested that ERK1/2 activation occurs in a KRAS-and BRAF-independent manner in endometrial cancer [34] . The uestion was whether BANCR promoted EC-cell proliferation, migration, and invasion through the ERK/MAPK signaling pathway.
According to the method in the study [35] , CNC network bioinformatics analysis by differential expression pro iles of LncRNAs and mRNAs was used to analysis the function of LncRNA through co-expression mRNA. For example, a report suggested a role for the lncRNA TK1 0605 (AK0 9380) in oligodendrocyte lineage commitment [36] . In the CNC network, TK1 0605 was co-expressed with Map6d1, a member of the STOP family that is responsible for the stabilization of neuronal microtubules [3 ] . CNC bioinformatics analysis found a potential co-expression relationship of BANCR with MMP2 and MMP1, which suggested us lncRNA BANCR might have similar function or regulative relation to MMP2/ MMP1. Dysregulation of MMP may promote migration and invasion of tumor cells [38] . In line with previous studies, MMP2 and MMP1 were highly expressed in type 1 EC tissues. And MMP2/MMP1 mRNA were positively correlated with lncRNA BANCR expression. Previous studies have reported that blocking the ERK/MAPK pathway inhibited colorectal cancer cell migration and invasion by down-regulating the expression of MMP [26] . We thus speculate that lncRNA BANCR can activate ERK/MAPK pathway that regulates MMP2 and MMP1 expression then to in luence EC cell biological effects.
In this study, P-MEK and P-ERK1/2 protein expression were signi icantly decreased in Ishikawa and HEC-1A cells transfected with si-BANCR, while T-MEK and T-ERK1/2 protein expression had not changed. However, expression of MMP2 and MMP1 mRNA and protein in Ishikawa and HEC-1A cells transfected with si-BANCR was signi icantly inhibited by U0126. These results showed that, in EC cells, the ERK/MAPK pathway played an important role in the regulation of MMP2 and MMP1 by lncRNA BANCR. LncRNA BANCR stimulated ERK/ MAPK pathway, and then upregulated MMP2 and MMP1 expression, which promoted the proliferation, migration, and invasion of Ishikawa and HEC-1A cells. It is interesting that, between cells transfected with si-BANCR and treated with U0126, we found no difference in MMP2 mRNA and protein levels. But there was signi icant difference in MMP1 mRNA and protein expression. This suggested that lncRNA BANCR regulated MMP2 more speci ically than MMP1 via ERK/MAPK pathway or that other upstream genes regulated MMP1 in type 1 EC cells in addition to BANCR, and which need to be further researched. And whether BANCR can directly regulate MMP2 and MMP1 expression also need to be further studied.
In conclusion, lncRNA BANCR was highly expressed in type 1 EC tissues, and took part in the progression of EC. Knockdown of BANCR blocked the ERK/MAPK signaling pathway that reduced MMP2 and MMP1 levels, which inhibited cell proliferation, migration, and invasion of EC cells. More animal studies and bioinformatics evaluations will help determine the mechanism of BANCR in type 1 EC. Because BANCR was found by RNA-se screening for transcripts affected by the expression of the oncogene BRAF V600E , the potential regulating relationship of the expression of BRAF or BRAF mutation and lncRNA BANCR in EC will be assessed in our future studies. Study of type 2 EC tissue will reveal differences in BANCR expression in type1 and type 2 EC that will help identify roles of lncRNA BANCR in the diagnosis, treatment and prognosis of EC.
